AUPO900297A0 - A method of modulating cellular activity - Google Patents
A method of modulating cellular activityInfo
- Publication number
- AUPO900297A0 AUPO900297A0 AUPO9002A AUPO900297A AUPO900297A0 AU PO900297 A0 AUPO900297 A0 AU PO900297A0 AU PO9002 A AUPO9002 A AU PO9002A AU PO900297 A AUPO900297 A AU PO900297A AU PO900297 A0 AUPO900297 A0 AU PO900297A0
- Authority
- AU
- Australia
- Prior art keywords
- cellular activity
- modulating cellular
- modulating
- activity
- cellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001413 cellular effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Food Science & Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO9002A AUPO900297A0 (en) | 1997-09-08 | 1997-09-08 | A method of modulating cellular activity |
EP98941157A EP1011654A4 (en) | 1997-09-08 | 1998-09-08 | A method of modulating cellular activity |
PCT/AU1998/000730 WO1999012533A1 (en) | 1997-09-08 | 1998-09-08 | A method of modulating cellular activity |
AU89658/98A AU757358B2 (en) | 1997-09-08 | 1998-09-08 | A method of modulating cellular activity |
CA2302838A CA2302838C (en) | 1997-09-08 | 1998-09-08 | Modulation of the sphingosine kinase signalling pathway |
JP2000510431A JP4570246B2 (en) | 1997-09-08 | 1998-09-08 | Methods for modulating cellular activity |
US09/977,217 US6649362B2 (en) | 1997-09-08 | 2001-10-16 | Screening method for an agent having an effect on a sphingosine kinase signaling pathway |
US10/679,485 US7172879B2 (en) | 1997-09-08 | 2003-10-07 | Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO9002A AUPO900297A0 (en) | 1997-09-08 | 1997-09-08 | A method of modulating cellular activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPO900297A0 true AUPO900297A0 (en) | 1997-10-02 |
Family
ID=3803288
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPO9002A Abandoned AUPO900297A0 (en) | 1997-09-08 | 1997-09-08 | A method of modulating cellular activity |
AU89658/98A Expired AU757358B2 (en) | 1997-09-08 | 1998-09-08 | A method of modulating cellular activity |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU89658/98A Expired AU757358B2 (en) | 1997-09-08 | 1998-09-08 | A method of modulating cellular activity |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1011654A4 (en) |
JP (1) | JP4570246B2 (en) |
AU (2) | AUPO900297A0 (en) |
CA (1) | CA2302838C (en) |
WO (1) | WO1999012533A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1192247T3 (en) * | 1999-05-13 | 2006-07-31 | Johnson & Johnson Pharm Res | Sphingosine kinase enzyme |
AUPQ744700A0 (en) * | 2000-05-11 | 2000-06-01 | Medvet Science Pty. Ltd. | A method of treatment and agents useful for same |
EP1195604A1 (en) * | 2000-09-29 | 2002-04-10 | Warner-Lambert Company | Methods and compositions for screening modulators of lipid kinases |
US6610534B2 (en) * | 2000-10-05 | 2003-08-26 | Novartis Ag | Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
WO2002098458A1 (en) * | 2001-06-07 | 2002-12-12 | Medvet Science Pty Ltd | Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
AU2003215426A1 (en) * | 2002-03-28 | 2003-10-13 | Medvet Science Pty. Ltd. | A method of modulating cellular activity |
WO2004035786A1 (en) * | 2002-10-14 | 2004-04-29 | Medvet Science Pty. Ltd. | A method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase |
EP1481680A1 (en) * | 2003-05-30 | 2004-12-01 | Aventis Pharma Deutschland GmbH | Use of S1P |
AU2005253643B2 (en) * | 2004-06-15 | 2011-12-01 | Medvet Science Pty. Ltd. | Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
JP2008502604A (en) * | 2004-06-15 | 2008-01-31 | メドベット サイエンス ピーティーワイ. リミティッド | Methods for modulating cellular activity, including sphingosine kinase, substances for modulating, and sphingosine kinase variants |
WO2006076767A1 (en) * | 2005-01-21 | 2006-07-27 | Medvet Science Pty. Ltd. | A method of treating cellular damage |
WO2012015758A2 (en) | 2010-07-30 | 2012-02-02 | Saint Louis University | Methods of treating pain |
WO2017015334A1 (en) | 2015-07-21 | 2017-01-26 | Saint Louis University | Compositions and methods for diagnosing and treating endometriosis-related infertility |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766111A (en) * | 1985-10-31 | 1988-08-23 | Trustees Of Boston University | Lipids with plasmin inhibitory properties |
DE3854940T2 (en) * | 1987-05-20 | 1996-07-11 | Rogosin Inst | RECONSTRUCTED HDL PARTICLES AND THEIR USE |
US5190876A (en) * | 1988-12-27 | 1993-03-02 | Emory University | Method of modifying cellular differentiation and function and compositions therefor |
CA2007507C (en) * | 1989-02-03 | 1998-05-19 | Yasuyuki Igarashi | Sphingosine and n-methyl-sphingosine as inhibitor of cell growth |
US5466716A (en) * | 1990-12-31 | 1995-11-14 | The Biomembrane Institute | Liposomal trimethylsphingosine |
AU679776B2 (en) * | 1993-07-23 | 1997-07-10 | Oncomembrane, Inc | N,N,N-trimethylsphingosine derivatives |
CA2208580A1 (en) * | 1994-12-29 | 1996-07-11 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
US5677189A (en) * | 1995-06-29 | 1997-10-14 | Oncomembrane, Inc. | Method for quantifying sphingosine and for diagnosing platelet activation |
JPH09176083A (en) * | 1995-12-28 | 1997-07-08 | Sankyo Co Ltd | New compound f-12509a |
-
1997
- 1997-09-08 AU AUPO9002A patent/AUPO900297A0/en not_active Abandoned
-
1998
- 1998-09-08 CA CA2302838A patent/CA2302838C/en not_active Expired - Lifetime
- 1998-09-08 EP EP98941157A patent/EP1011654A4/en not_active Withdrawn
- 1998-09-08 JP JP2000510431A patent/JP4570246B2/en not_active Expired - Lifetime
- 1998-09-08 WO PCT/AU1998/000730 patent/WO1999012533A1/en active IP Right Grant
- 1998-09-08 AU AU89658/98A patent/AU757358B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2302838C (en) | 2010-03-16 |
EP1011654A1 (en) | 2000-06-28 |
AU8965898A (en) | 1999-03-29 |
JP2001515857A (en) | 2001-09-25 |
JP4570246B2 (en) | 2010-10-27 |
WO1999012533A1 (en) | 1999-03-18 |
EP1011654A4 (en) | 2004-09-15 |
AU757358B2 (en) | 2003-02-20 |
CA2302838A1 (en) | 1999-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5827298A (en) | Method of making retroreflective elements | |
AP9500756A0 (en) | Modulation of cellular activity | |
IL133822A0 (en) | Aroylpiperazines for modulating sexual activity | |
AU4141797A (en) | Arrangement of a mobile accommodation of activities | |
AU5881998A (en) | Modulator and modulation method | |
AU2029995A (en) | Method of operation of a radio system | |
AUPO900297A0 (en) | A method of modulating cellular activity | |
AU9771498A (en) | Arrangement and method relating to radio communication | |
AU7831594A (en) | A method of promoting cellular function | |
AUPO863697A0 (en) | A computerised method of compiling reports | |
AU8742398A (en) | Method of reducing a schiff base | |
GB2327175B (en) | Method of operating a cellular network | |
AUPO882497A0 (en) | A method of genotyping | |
AU8817398A (en) | Method of drug selection | |
AU2003204254A1 (en) | A Method of Modulating Cellular Activity | |
AUPP646498A0 (en) | A method of modulating ion channel functional activity | |
AU1760499A (en) | Catalyst and method for producing polytetrahydrofuran | |
AUPO937097A0 (en) | Method | |
AUPO870297A0 (en) | Method | |
AU7908198A (en) | A method for pre-fibrillation of lyocell | |
AU1487199A (en) | A communication method and system | |
AUPP487098A0 (en) | A method of modulating cellular adhesion | |
ZA957223B (en) | Modulation of cellular activity | |
AUPQ075799A0 (en) | A method of modulating cellular adhesion | |
AUPO958197A0 (en) | A method of protein engineering |